| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000014845 |
| Receipt No. | R000017147 |
| Official scientific title of the study | Effects of perioperative nutritional intervention on liver regeneration after hepatectomy. |
| Date of disclosure of the study information | 2014/08/13 |
| Last modified on | 2017/09/04 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Effects of perioperative nutritional intervention on liver regeneration after hepatectomy. | |
| Title of the study (Brief title) | Effects of perioperative nutritional intervention on liver regeneration after hepatectomy. | |
| Region |
|
|
| Condition | ||
| Condition | hepatocellular carcinoma cases require hepatectomy | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the efficacy of perioperative nutritional intervention for hepatocellular carcinoma with hypoalbuminemia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | postoperative improvement of liver function |
| Key secondary outcomes | postoperative course
liver regeneration rate |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Branched-chain amino acid granules(BCAA, Livact) is orally administered three times a day for 2 weeks prior to hepatectomy and 1 month after hepatectomy(hypoalbuminemia group). | |
| Interventions/Control_2 | No administration of BCAA (hypoalbuminemia group). | |
| Interventions/Control_3 | No administration of BCAA (normal albumin level group). | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)hepatocellular carcinoma(including combined hepatocellular and cholangiocarcinoma) by preoperative imaging examination
2)planned hepatectomy 3)ECOG Performance Status 0 to 2 4)appropriate liver function for hepatectomy according to the results of the Child-Pugh classification and the ICG-R15 test (within 30 days before the registration) 5)written informed consent |
|||
| Key exclusion criteria | 1)severe diabetes, or suspected abnormal sugar metabolism because of high dosage of steroids
2)abnormal amino acid metabolism 3)history of hypersensitivity against Livact 4)pregnant or willing to get pregnant 5)patien's offer discontinuation of the study 6)doctor's decision not to be registered to the study |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Osamu Itano |
| Organization | Department of Surgery, Keio University School of Medicine |
| Division name | Department of Surgery |
| Address | Shinanomachi 35, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| contact@keio-hpbts.jp | |
| Public contact | |
| Name of contact person | Hiroshi Yagi |
| Organization | Department of surgery, Keio University, school of medicine |
| Division name | Department of Surgery |
| Address | Shinanomachi 35, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| Homepage URL | |
| contact@keio-hpbts.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 慶応義塾大学病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017147 |